BioCentury
ARTICLE | Clinical News

PRTX-100: Preliminary Phase I/II data

May 9, 2016 7:00 AM UTC

Preliminary data from 8 patients with active RA in the per protocol (PP) population of part 1 of the 2-part, open-label, U.S. Phase I/II SPARTA-II (PRTX-100-105) trial showed that IV PRTX-100 for 6 mo...